Projected revenue — where will it come from?
As we know, early stage biotech companies, often with market capitalizations of 100s of millions of dollars and facing 100s of millions in expenses before having any revenues, often have no revenues, Stellar, with an opening market cap of less than $10M has had revenues from sales of product for several years. Early revenue projections are based on orders we’ve been told to expect from current customers. Beyond that, Stellars revenue model does assume that KLH demand is driven by the advancement of 3-4 cancer vaccines through clinical trials over the next three years (out of 30 + in process), with the approval of one or more of these candidate products within the next five years. However, because of the attrition rate of vaccine candidates experienced in the past, Stellar is focusing product development on a KLH strategy that is not dependent on the cancer vaccine segment, and can be advanced by Stellar without dependence on the success of customers clinical programs. This is related t
Related Questions
- What protections do the taxpayers have in the event that the SportsPlex does not generate the amount of revenue that is projected?
- Given the projected revenue declines, how much will the University need to cut from the 2010 budget to balance it?
- What is the additional projected revenue for residential franchise fees?
